Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | SHBG | P04278 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 5/20 | 0.41 |
| ▸ | MDH1 | P40925 | 9/20 | 0.40 |
| ▸ | MDH2 | P40926 | 9/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | APAF1 | O14727 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | ERBB2 | P04626 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 2/20 | 0.39 |
| ▸ | FYN | P06241 | 2/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.39 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13018431 | 0.83 | CYP3A4 (0.53) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 | |
| SCHEMBL9555577 | 0.83 | CYP3A4 (0.53) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 | |
| SCHEMBL9769325 | 0.81 | CYP3A4 (0.51) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 | |
| SCHEMBL28747587 | 0.79 | CYP3A4 (0.61) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 | |
| SCHEMBL480668 | 0.79 | CYP3A4 (0.61) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 | |
| SCHEMBL7166618 | 0.78 | CYP3A4 (0.59) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 | |
| SCHEMBL8140565 | 0.77 | MAPT (0.48) | SMN1; SMN2MAPTALDH1A1LMNATSHR | |
| SCHEMBL22773184 | 0.76 | CYP3A4 (0.58) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 | |
| SCHEMBL13019868 | 0.76 | CYP3A4 (0.58) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 | |
| SCHEMBL988235 | 0.76 | CYP3A4 (0.58) | CYP3A4SMN1; SMN2SHBGHIF1AMDH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117883308-A | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one alkyl or alkylene carbonate | 莱雅公司 | 2024-04-16 | — | — | CN | disclosed |
| EP-4262714-A1 | COSMETIC COMPOSITION COMPRISING A MEROCYANINE, A TRIAZINE UV-SCREENING AGENT, AND A POLYSACCHARIDE MODIFIED WITH HYDROPHOBIC CHAINS | L'OREAL (FR) | 2023-10-25 | — | — | EP | disclosed |
| EP-4262719-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE CITRIC ACID ESTER | L'OREAL (FR) | 2023-10-25 | — | — | EP | disclosed |
| US-11679069-B2 | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one alkyl or alkylene carbonate | L'OREAL (FR) | 2023-06-20 | — | — | US | disclosed |
| WO-2022129039-A1 | COSMETIC COMPOSITION COMPRISING A MEROCYANINE, A TRIAZINE UV-SCREENING AGENT, AND A POLYSACCHARIDE MODIFIED WITH HYDROPHOBIC CHAINS | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| WO-2022129059-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE CITRIC ACID ESTER | L'OREAL (FR) | 2022-06-23 | — | — | WO | disclosed |
| US-20210251868-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE ALKYL OR ALKYLENE CARBONATE | L'OREAL (FR) | 2021-08-19 | — | — | US | disclosed |
| EP-3827807-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE N-SUBSTITUTED AMIDE | L'OREAL (FR) | 2021-06-02 | — | — | EP | disclosed |
| US-11000460-B2 | Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a C1—C4 monoalkanol | L'OREAL (FR) | 2021-05-11 | — | — | US | disclosed |
| EP-3813779-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE ALKYL OR ALKYLENE CARBONATE | L'OREAL SA (FR) | 2021-05-05 | — | — | EP | disclosed |
| WO-2004085412-A2 | SYMMETRICAL TRIAZINE DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-10-07 | — | — | WO | disclosed |
| US-20040191191-A1 | Symmetrical triazine derivatives | CIBA SPECIALTY CHEMICALS CORP. | 2004-09-30 | — | — | US | disclosed |
| WO-2004052837-A2 | AMINO SUBSTITUTED HYDROXYPHENYL BENZOPHENONE DERIVATIVES | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-06-24 | — | — | WO | disclosed |
| WO-2004006878-A1 | MEROCYANINE DERIVATIVES FOR COSMETIC USE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-01-22 | — | — | WO | disclosed |
| US-4551420-A | ULTRAVIOLET RAY ABSORBING POLYMER LATEX | FUJI PHOTO FILM CO., LTD. (JP) | 1985-11-05 | — | — | US | disclosed |
| US-4464462-A | ULTRAVIOLET RAY-ABSORBING ACRYLIC POLYMER LATEX; ANTISTATIC AGENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1984-08-07 | — | — | US | disclosed |
| US-4455368-A | Silver halide photographic light-sensitive material containing a UV absorbing polymer latex | FUJI PHOTO FILM CO., LTD. (JP) | 1984-06-19 | — | — | US | disclosed |
| US-4443534-A | VINYL CHLORIDE HOMO- OR COPOLYMER, OR ACRYLAMIDE OR ACRYLIC ESTER HOMO- OR COPOLYMER | FUJI PHOTO FILM CO., LTD. (JP) | 1984-04-17 | — | — | US | disclosed |
| US-4244848-A | HEAT RESISTANT STABILIZERS COMPRISING AT LEAST ONE ZINC, DIALKYLTIN, ALKALI METAL OR ALKALINE EARTH METAL ORGANIC PHOSPHATE ESTER SALT AND AT LEAST ONE B-DIKETONE | ARGUS CHEMICAL CORPORATION (US) | 1981-01-13 | — | — | US | disclosed |
| US-4195999-A | Silver halide photographic material containing ultraviolet light absorbing agent | FUJI PHOTO FILM CO., LTD. (JP) | 1980-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11679069-B2 | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one alkyl or alkylene carbonate | KRT18, DSG1, CUTA | CYP3A4 3822/4885SMN1; SMN2 4057/4885SHBG 2061/4885 |
| US-20210251868-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE ALKYL OR ALKYLENE CARBONATE | KRT18, DSC1, DSG1 | CYP3A4 3480/4885SMN1; SMN2 3998/4885SHBG 2738/4885 |
| US-20040191191-A1 | Symmetrical triazine derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, RNF168, CYC1 | CYP3A4 668/4885SMN1; SMN2 4354/4885SHBG 380/4885 |
| US-11000460-B2 | Cosmetic or dermatological composition comprising a merocyanine, an oily phase and a C1—C4 monoalkanol | KRT18, C1S, C1R | CYP3A4 1866/4885SMN1; SMN2 4497/4885SHBG 2809/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.